310 related articles for article (PubMed ID: 31219620)
1. Giant cell tumors combined with secondary aneurysmal bone cysts are more likely to develop postoperative recurrence: A retrospective study of 256 cases.
Tang H; Moro A; Feng W; Lai Y; Xiao Z; Liu Y; Wang K
J Surg Oncol; 2019 Sep; 120(3):359-365. PubMed ID: 31219620
[TBL] [Abstract][Full Text] [Related]
2. Recurrence Rates and Risk Factors for Primary Giant Cell Tumors around the Knee: A Multicentre Retrospective Study in China.
Hu P; Zhao L; Zhang H; Yu X; Wang Z; Ye Z; Wu S; Guo S; Zhang G; Wang J; Ning X; Hu Y; Zhang Y
Sci Rep; 2016 Nov; 6():36332. PubMed ID: 27827384
[TBL] [Abstract][Full Text] [Related]
3. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance feature of "paintbrush borders" sign as a novel way to predict recurrence of giant cell tumor of bone after curettage: a pilot study.
He Y; Wang J; Zhang J; Du L; Lu Y; Xu J; Yuan F; Tan Y; Ding X
J Int Med Res; 2018 Feb; 46(2):710-722. PubMed ID: 29239274
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of fracture following curettage for bone giant cell tumors of the extremities.
Tsukamoto S; Mavrogenis AF; Akahane M; Honoki K; Kido A; Tanaka Y; Donati DM; Errani C
BMC Musculoskelet Disord; 2022 May; 23(1):477. PubMed ID: 35590280
[TBL] [Abstract][Full Text] [Related]
6. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution.
Niu X; Zhang Q; Hao L; Ding Y; Li Y; Xu H; Liu W
J Bone Joint Surg Am; 2012 Mar; 94(5):461-7. PubMed ID: 22398741
[TBL] [Abstract][Full Text] [Related]
7. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
[TBL] [Abstract][Full Text] [Related]
8. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
[TBL] [Abstract][Full Text] [Related]
9. Giant cell tumor of bone with secondary aneurysmal bone cyst does not have a higher risk of local recurrence.
Tsukamoto S; Aiba H; Righi A; Nitta Y; Traversari M; Mavrogenis AF; Honoki K; Tanaka Y; Donati DM; Errani C
J Surg Oncol; 2023 Aug; 128(2):350-358. PubMed ID: 37053028
[TBL] [Abstract][Full Text] [Related]
10. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
Gouin F; Dumaine V;
Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
[TBL] [Abstract][Full Text] [Related]
11. Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone.
Sano K; Suehara Y; Okubo T; Sasa K; Kurihara T; Akaike K; Kubota D; Torigoe T; Hasegawa N; Ishii M; Nakamura Y; Kim Y; Takagi T; Kaneko K; Hayashi T; Saito T
J Orthop Surg (Hong Kong); 2020; 28(2):2309499020929786. PubMed ID: 32539628
[TBL] [Abstract][Full Text] [Related]
12. Effect of adjuvant therapies on recurrence in aneurysmal bone cysts.
Keçeci B; Küçük L; Isayev A; Sabah D
Acta Orthop Traumatol Turc; 2014; 48(5):500-6. PubMed ID: 25429574
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of 51 intralesionally treated cases with progressed giant cell tumor of the bone: local adjuvant use of hydrogen peroxide reduces the risk for tumor recurrence.
Omlor GW; Lange J; Streit M; Gantz S; Merle C; Germann T; Mechtersheimer G; Fellenberg J; Lehner B
World J Surg Oncol; 2019 Apr; 17(1):73. PubMed ID: 31014317
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Preoperative CT and MR Imaging Findings in the Prediction of Postoperative Recurrence of Spinal Giant Cell Tumor of Bone.
Wang QZ; Zhang EL; Xing XY; Su MY; Lang N
Orthop Surg; 2021 Dec; 13(8):2405-2416. PubMed ID: 34841660
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of histone 3 mutations in osteoclast-rich bone tumors.
Nohr E; Lee LH; Cates JM; Perizzolo M; Itani D
Hum Pathol; 2017 Oct; 68():119-127. PubMed ID: 28882701
[TBL] [Abstract][Full Text] [Related]
16. Similar local recurrence but better function with curettage versus resection for bone giant cell tumor and pathological fracture at presentation.
Tsukamoto S; Mavrogenis AF; Tanzi P; Leone G; Righi A; Akahane M; Kido A; Honoki K; Tanaka Y; Donati DM; Errani C
J Surg Oncol; 2019 Jun; 119(7):864-872. PubMed ID: 30734307
[TBL] [Abstract][Full Text] [Related]
17. Use of extended curettage with osteotomy and fenestration followed by reconstruction with conservation of muscle insertion in the treatment of Enneking stage II locally aggressive bone tumor of the proximal extremities: resection and treatment of bone tumors.
Chen F; Xia J; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J
World J Surg Oncol; 2013 Mar; 11():54. PubMed ID: 23497479
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture.
Medellin MR; Fujiwara T; Tillman RM; Jeys LM; Gregory J; Stevenson JD; Parry M; Abudu A
Bone Joint J; 2018 Dec; 100-B(12):1626-1632. PubMed ID: 30499317
[TBL] [Abstract][Full Text] [Related]
19. Denosumab May Increase the Risk of Local Recurrence in Patients with Giant-Cell Tumor of Bone Treated with Curettage.
Errani C; Tsukamoto S; Leone G; Righi A; Akahane M; Tanaka Y; Donati DM
J Bone Joint Surg Am; 2018 Mar; 100(6):496-504. PubMed ID: 29557866
[TBL] [Abstract][Full Text] [Related]
20. Curettage as first surgery for bone giant cell tumor : adequate surgery is more important than oncology training or surgical management by high volume specialized teams.
Tsukamoto S; Mavrogenis AF; Tanzi P; Leone G; Akahane M; Tanaka Y; Errani C
Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):3-9. PubMed ID: 31520122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
